(1)
Limbong, G. ANALYSIS OF THE COMPANY’S FINANCIAL PERFORMANCE BEFORE AND DURING THE COVID-19 PANDEMIC (2019-2020) IN PHARMACEUTICAL SECTOR COMPANIES LISTED ON THE IDX. JM 2022, 10, 156-165.